Since 1986, Ovarian Cancer Action has hosted the HHMT International Forum, bringing together international leaders in the field of ovarian cancer. The aim of the Forum is to foster collaboration between scientists, worldwide, in order to accelerate the rate of progression towards major scientific discovery.
As a result, recent years have seen an explosion in our understanding of ovarian cancer.
Previous HHMT International Forums have resulted in collaborative papers published in prestigious journals, including Nature Reviews Cancer, a monthly scientific review for oncologists. Since the last meeting there has been a wave of new research collaborations across all seven of the key priority areas identified in the 2015 paper.
“If ovarian cancer is going to be cured it will be largely by the people in this room,”The concluding statement by Dr Karen Lu of MD Anderson Cancer Center at the 2015 HHMT International Forum on Ovarian Cancer.
These papers, and subsequent work in the field, demonstrate the immense value of bringing world experts in the field of ovarian cancer research together, to make a real impact on the lives of women affected by the disease.
This September we will be hosting the 14th HHMT International Forum on Ovarian Cancer, which will focus on answering the important question of how we can achieve meaningful and lasting responses to immunotherapies in patients with ovarian cancers.
Further to that, we will be awarding a significant grant of up to £600,000 for an immunotherapy or immunology-based research project to improve outcomes and transform treatment for women with ovarian cancer.
By investing in immunotherapy research now, we hope that we will be able to replicate the success seen in other cancers for ovarian cancer.